Three months ago, Infosys traded its habit of raising guidance for a more defensive posture, trimming the top of its fiscal 2027 outlook as a client program termination, a shrinking European manufacturing account and heavier AI-driven pricing pressure ate into the legacy business. The upcoming report, due before the open on October 23, is the first real check on whether that reset was a one-time clearing of the decks or the start of a longer slide in organic growth. The stock's rebound since the last report suggests investors have chosen the more charitable reading.

The Street is asking for modest progress. Consensus calls for earnings of $0.21 per share, up about 5% from a year ago, on revenue of $5.18 billion, roughly 2.1% higher. The Earnings Whisper sits right on consensus, so there is no hidden bar to clear. What matters more is the sequential picture: revenue was $5.08 billion last quarter, so the forecast implies about 2% growth from the June quarter. That looks respectable until you remember that the newly closed Optimum Healthcare and Stratus acquisitions are expected to contribute about 1.7 points to full-year growth, while management's own organic midpoint fell to roughly 0.8%. In other words, much of the expected improvement is bought, not built.

The guidance math reinforces that point. Infosys now projects fiscal 2027 revenue of $20.46 billion to $20.76 billion after lopping $100 million off the top of its prior range, and consensus of $20.47 billion sits essentially at the floor. Analysts are not assuming a recovery, which lowers the risk of disappointment but also means a reaffirmed range would merely confirm the cautious status quo. A further cut, particularly one that drags the bottom end lower, would signal that the deflation and volume weakness flagged last quarter are spreading rather than stabilizing.

The operating details will carry the story. Management warned that the termination in its energy, utilities, resources and services vertical would cascade into this quarter, and that the European manufacturing ramp-down would cost more than a point of annual revenue. Investors should look for confirmation that those headwinds are now largely in the run rate. Just as important is whether client volumes recover toward normal seasonality after a soft first quarter, and whether net pricing, pressured by AI productivity pass-throughs on renewals, stops deteriorating. On the positive side, AI services reached 8.2% of revenue and were growing at a strong double-digit sequential clip, while large-deal bookings rose to $3.6 billion. Continued gains in both would support the argument that Infosys can grow its new work faster than AI erodes its old work. Margins deserve attention too, since the company held its 20% to 22% band despite a 50 basis point drag from acquisitions; last quarter's utilization and gross margin gains need to persist for that to hold.

Sentiment has swung sharply. Heading into last quarter's report, readings were nearly 49% bearish; they now sit about 12% bullish. The shares have climbed 10.5% since the last report, outpacing the S&P 500 by more than 6 points. Still, at $11.48 the stock trades well below its 200-day moving average of $13.19 and roughly 10% under its post-earnings high of $12.72, so this is a recovery from depressed levels rather than a breakout.

Ultimately, the quarter hinges on organic momentum. If Infosys shows that volumes have steadied, the client-specific losses are fully absorbed and AI revenue is scaling fast enough to offset pricing compression, the guidance cut will look like a floor. If growth again leans mainly on acquisitions while the legacy base keeps shrinking, the improved mood around the stock may prove premature.